ReNew Announces Results for the Second Quarter for Fiscal Year 2026 (Q2 FY26), Ended September 30, 2025; Reports 84% Net Profit Increase YOY in H1 FY2026 November 10, 2025 ReNew Energy Global Plc (“ReNew” or “the Company”) (Nasdaq: RNW, RNWWW), a leading decarbonization solutions company, today announced its unaudited consolidated IFRS results for the three-month period ended September 30, 2025. Operating Highlights: As of September 30, 2025, the Company’s portfolio consisted of ~18.5 GWs (+1.1 GWh BESS), compared to ~15.6 GWs as of September [...]
Jensen Partners Wins Dual Honors at 2025 Private Equity Wire US Awards—Excellence in Investor Relations & Asset Raising Recruitment and Executive Search November 10, 2025 Awards underscore Jensen Partners’ preeminent human capital expertise and leadership across the alternative asset management landscape
Lone Star Announces Sale of Multi-Property Real Estate Portfolio Across Texas November 10, 2025 Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VI, L.P. has successfully completed the sale of three multifamily properties across Texas which were sold to three separate buyers. Financial terms of the transaction were not disclosed. The entire portfolio totaled 606 property units: a 208-unit garden style [...]
Yubico to Accelerate Passkey Adoption with Identity Verification Partnerships, Bolstering Defense Against AI-Driven Fraud November 10, 2025 YubiKey as a Service to support IDV with HYPR and Nametag Unifying Secure Onboarding and Verified Trust
Almirall’s 2025 9M Results November 10, 2025 Almirall continues its sustained growth trajectory in 9M 2025 - delivering 12.8% net sales growth, strong dermatology performance, solid commercial execution in Europe, and further pipeline progress Sustained strong growth momentum with 12.8% Net Sales YoY increase to a total of €820.7 MM, with biologics continuing to deliver double-digit growth YoY and dermatology sales in Europe increasing 24.5% YoY further advancing Almirall´s leadership in medical dermatology. EBITDA increase of 27.1% YoY in line with expectations, reaching a total of €180.7 MM. On track to meet 2025 guidance driven by biologics growth and operational strength. Performance continues to be primarily driven by the biologics portfolio, with Ilumetri® net sales increasing 12.1% YoY (total of €170.9 MM), and Ebglyss® net sales of €75.5 MM – reflecting a more than 3x increase YoY as European markets are ramping up after launch. Solid performance of the broad dermatology product portfolio with Wynzora® growing 32.4% YoY to a total of €25.4 MM, and Klisyri® growing 22.6% YoY to a total of €20.1 MM, further enhancing Almirall’s position as trusted partner for patients and dermatologists. Continued R&D pipeline progress includes the start of the phase II study of the anti-IL-1RAP mAb, and plan to initiate three additional proof-of-concept studies over the coming 9 to 12 months.
OMRON Releases the “Medium-Term Roadmap SF 2nd Stage” November 8, 2025 OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November 7, 2025 (JST). This Roadmap presents the Group’s vision and growth strategies through 2030, which are disclosed on our corporate website. Overview of the “Medium-Term Roadmap SF 2nd Stage” Since April 2024, [...]
26th UN Tourism General Assembly kicks off in Riyadh November 7, 2025 UN Tourism marks 50 years of global cooperation as leaders from across the industry gather to shape the future of tourism. His Excellency Ahmed Al Khateeb, Minister of Tourism – “The Kingdom will play an integral part in ensuring one of the world’s most powerful generators of jobs and GDP grows in harmony with the Sustainable Development Goals.” UN Tourism Secretary-General Zurab Pololikashvili – “The UN Tourism General Assembly brings together tourism leaders from across the world to set the agenda and build a more innovative and inclusive sector. From Riyadh, we will set the agenda for tourism for the years ahead.”
Xsolla Partners With Deloitte Turkiye and Lorien Accelerator as Category Sponsor for Gaming Awards at Fast 50 Türkiye 2025 Program November 7, 2025 Celebrating Turkey’s Gaming Industry with High-Impact Sponsorship and Industry Panel
ReNew and Asian Development Bank Announce US$331 million Deal for a Large-Scale Renewable Energy Project in Andhra Pradesh November 7, 2025 Part of a US$477 million deal secured, ReNew will receive US$331 million from ADB, and the balance US$146 million will be arranged by ADB through other lenders Project expected to generate 1,641 GWh of clean energy annually, boosting grid stability and accelerating India’s energy transition
TITAN Group’s Credit Rating Improved to “BB+ with Positive Outlook” by S&P Global Ratings November 7, 2025 S&P Global Ratings has revised TITAN SA’s (Brussels:TITC) outlook to ‘Positive’ while affirming its ‘BB+’ long-term credit rating. This decision reflects TITAN Group’s continued robust financial performance and the effectiveness of its supportive financial policies. S&P’s report highlights the Group’s resilient results driven by its strong operations. The positive outlook demonstrates S&P views that they [...]